These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30349600)

  • 1. Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin - a UK Perspective.
    Hellmund R; Weitgasser R; Blissett D
    Eur Endocrinol; 2018 Sep; 14(2):86-92. PubMed ID: 30349600
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
    Hellmund R; Weitgasser R; Blissett D
    Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis Estimating the Potential Cost Impact of Utilizing Flash Glucose Monitoring with Optional Alarms in Swedish Adults with Diabetes with Impaired Awareness of Hypoglycaemia, Using Intensive Insulin.
    Blissett DB; Attvall S; Hellmund RA
    Diabetes Ther; 2021 Aug; 12(8):2179-2193. PubMed ID: 34232483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden.
    Bilir SP; Hellmund R; Wehler E; Li H; Munakata J; Lamotte M
    Eur Endocrinol; 2018 Sep; 14(2):80-85. PubMed ID: 30349599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden.
    Bilir SP; Hellmund R; Wehler B; Li H; Munakata J; Lamotte M
    Eur Endocrinol; 2018 Sep; 14(2):73-79. PubMed ID: 30349598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in China.
    Zhao X; Ming J; Qu S; Li HJ; Wu J; Ji L; Chen Y
    Diabetes Ther; 2021 Dec; 12(12):3079-3092. PubMed ID: 34689295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.
    Del Prato S; Giorgino F; Szafranski K; Poon Y
    Diabetes Obes Metab; 2024 Jun; ():. PubMed ID: 38853717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.
    Tunis SL; Minshall ME
    Curr Med Res Opin; 2010 Jan; 26(1):151-62. PubMed ID: 19919376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost Analysis of FreeStyle Libre
    Oyagüez I; Gómez-Peralta F; Artola S; Carrasco FJ; Carretero-Gómez J; García-Soidan J; Gómez-Huelgas R; Merino-Torres JF; Pérez A
    Diabetes Ther; 2021 Sep; 12(9):2329-2342. PubMed ID: 33948909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of the FreeStyle Libre
    Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
    Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
    Malanda UL; Welschen LM; Riphagen II; Dekker JM; Nijpels G; Bot SD
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005060. PubMed ID: 22258959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment.
    Ajjan R; Bilir SP; Hellmund R; Souto D
    Diabetes Ther; 2022 Dec; 13(11-12):1933-1945. PubMed ID: 36287387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-monitoring of blood glucose in type 2 diabetes: systematic review.
    Clar C; Barnard K; Cummins E; Royle P; Waugh N;
    Health Technol Assess; 2010 Mar; 14(12):1-140. PubMed ID: 20226138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.
    Blissett R; Blissett D; Levrat-Guillen F; Deshmukh H; Wilmot EG; Ryder REJ; Walton C; Sathyapalan T
    BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35346970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus.
    Oyagüez I; Merino-Torres JF; Brito M; Bellido V; Cardona-Hernandez R; Gomez-Peralta F; Morales-Perez F
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32699114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.
    Haak T; Hanaire H; Ajjan R; Hermanns N; Riveline JP; Rayman G
    Diabetes Ther; 2017 Jun; 8(3):573-586. PubMed ID: 28401454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
    Parekh W; Streeton SE; Baker-Knight J; Montagnoli R; Nicoziani P; Marchesini G
    Diabetes Ther; 2018 Jun; 9(3):1037-1047. PubMed ID: 29600505
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.